REsuLTs
The mean values and standard deviation are shown in Mean ALT activity in recipients was slightly higher than in donors. ALT activity over 50 IU/l was observed only in 8 donors and in 15 recipients (50%) (TAbLE 2). In recipients, the baseline ALT activity was significantly lower than at days 1 and 3 after transplantation. Mean AST activity did not differ significantly between donors and recipients, although it was 60% higher in recipients than in donors (TAbLE 2) . AST activity increased significantly at days 1 and 3 after transplantation compared with the baseline values. AST activity at day 3 was significantly lower than at day 1, but it did not achieve normal levels (<50 IU/l) in any of the recipients.
Mean baseline GGT activity in recipients was higher than in donors (P = nonsignificant). Unlike ALT and AST activity, the baseline GGT activity dropped significantly at day 1 and increased significantly at day 3 after transplantation.
types of endogenous methylated arginines are known, including ADMA, symmetric dimethylarginine (SDMA), and N-monomethylarginine (NMA). NMA is a weaker NOS inhibitor than ADMA, and its plasma levels are 10-fold lower.
4
Plasma SDMA and ADMA levels are almost equal, 5 but SDMA does not influence the synthesis of NO. 6 Normal plasma levels of ADMA, SDMA and L-arginine are 0.36-1.17 μmol/l, 7 0.46-0.54 μmol/l, 8 and 40-100 μmol/l, respectively. 9 ADMA deteriorates vascular flow, enhances atherosclerosis, and inhibits angiogenesis. 10 Elevated ADMA levels are observed in patients with kidney impairment, 4 arterial hypertension, hypercholesterolemia, diabetes mellitus, ischemic heart disease, pregnancy-induced hypertension, 8 atherosclerosis, 10 heart failure, 11 primary pulmonary hypertension, 12 arteriosclerosis obliterans, 13 portal hypertension, 14 hypopituitarism, 15 subarachnoid hemorrhage, 16 and systemic inflammatory response syndrome. 17 In some clinical entities, such as Alzheimer's disease, septic shock, and neoplastic angiogenesis, NO seems to be a pathogenetic factor. Thus, ADMA appears to be beneficial in the therapy of these pathological conditions.
18 The synthesis of ADMA is dependent on L-arginine methylation and on protein transformation rate. 9 More than 90% of ADMA and NMA is decomposed by hepatic dimethylarginine dimethylaminohydrolase (DDAH).
19 Methylarginines bind to proteins and therefore are poorly eliminated by hemodialysis. Contrary to ADMA, SDMA is excreted into urine and is easily eliminated by hemodialysis, but is not metabolized by DDAH. 5 Because reperfusion of the transplanted liver is a factor potentially injuring vascular endothelium (the main site of NOS activity), an alteration in the relationship between NO, ADMA, and L-arginine may be expected. These observations have provided the pathophysiological background of the current study, which aimed to answer the following questions: Do patients with end-stage liver failure have different levels of ADMA, SDMA, and L-arginine from liver donors? Is estimation of ADMA, SDMA, and L-arginine of diagnostic value in patients after liver transplantation? donors. At day 3, ADMA levels in recipients were significantly higher compared with the baseline values and those at day 1 (TAbLE 2, FIGuRE 2 ). Baseline SDMA levels were similar in donors and recipients. In recipients at day 3, SDMA levels were significantly higher than before transplantation (TAbLE 2, FIGuRE 2) .
The ADMA/SDMA ratio in liver recipients at baseline was not significantly higher than that in donors, showing a tendency to decrease at day 1 after transplantation and showing similar values to those in donors at day 3 (TAbLE 2) .
Changes in SDMA (ΔSDMA) and creatinine (Δcreatinine) levels in recipients between days 0 and 1 and days 1 and 3, respectively, increased nonsignificantly. There were no changes in the ΔSDMA / Δcreatinine ratio (TAbLE 2) .
Recipients showed higher baseline L-arginine levels than donors (nonsignificant). L-arginine levels increased significantly at day 3 after transplantation and were twice as high as in donors. L-arginine levels at day 3 were significantly higher than before transplantation (TAbLE 2) .
Correlations In donors, a significant negative correlation between SDMA levels and INR and a significant positive correlation between SDMA and creatinine levels were observed. In recipients, a strong correlation between SDMA and creatinine levels, a significant positive correlation between ADMA and bilirubin levels, and a significant negative correlation between ADMA concentration and INR were observed before transplantation (TAbLE 3) .
In recipients at day 1, a significant negative correlation was observed in recipients between SDMA levels and the activity of ALT, AST, and GGT as well as the level of albumin. In contrast, positive correlations were reported between creatinine and SDMA concentration, L-arginine levels, and INR and between ADMA and albumin levels.
In recipients at day 3, similarly to day 1, a significant negative correlation was observed between SDMA levels and AST activity, between SDMA levels and GGT activity, and between ADMA levels and INR. Finally, a significant positive correlation was found between SDMA and creatinine levels.
In summary, liver recipients before transplantation showed a slightly higher GGT activity, higher bilirubin concentration, and lower sodium levels.
After liver transplantation, we observed a significant increase in the activity of ALT and AST as well as in the plasma levels of creatinine, ADMA, SDMA, and L-arginine. Morover, we observed a significant decrease in bilirubinemia.
dIsCussION The present study revealed that liver recipients have slightly elevated ALT and GGT activity, higher INR values, elevated bilirubin levels, and significantly lower sodium levels than donors. These results may prove the presence of hepatocyte injury and deteriorated
The albumin level in recipients was slightly lower than in donors. It decreased significantly at days 1 and 3 after transplantation.
Recipients at day 0 and donors had almost identical baseline INR values, which transiently increased at day 1 after transplantation and subsequently decreased to baseline values.
As expected, bilirubin levels in donors were normal. Recipients at day 0 had 8-fold higher bilirubin levels compared with donors. Bilirubinemia decreased significantly at days 1 and 3 after transplantation but did not achieve normal levels (TAbLE 2) .
Creatinine levels in recipients were nonsignificantly lower than in donors (TAbLE 2, FIGuRE 1) . In one-third of the recipients and in 3 donors, creatinine levels were below 70 μmol/l. At day 1 after transplantation, a significant rise of creatinine levels was observed and was even higher at day 3.
Sodium levels in recipients were lower than in donors at all time points (TAbLE 2). In 22 donors, sodium levels were above 145 mmol/l. In almost all recipients, plasma sodium levels normalized after transplantation.
ADMA levels in recipients before transplantation were not significantly different from those in FIGuRE 1 Serum creatinine levels in donors and in recipients before transplantation (day 0) and at days 1 and 3 after transplantation nificant negative correlation with the activity of the studied enzymes.
Correlation results may suggest that the pathways of ADMA and SDMA synthesis are partially metabolism of porphyrins. Cirrhotic patients had similar ADMA, SDMA, and L-arginine levels as donors. Only SDMA levels showed a sig- Data presented as mean ± standard deviation; for significant differences, the Pearson correlation coefficient was used a significant differences between donors and recipients at day 0 b significant differences between donors and recipients at day 1 c significant differences between recipients at days 0 and 1 d significant differences between recipients at days 1 and 3 e significant differences between recipients at days 0 and 3
Abbreviations: ADMA -asymmetric dimethylarginine, ALT -alanine transaminase, AST -aspartate transaminase, GGT -γ-glutamyltranspeptidase, INR -international normalized ratio, SDMA -symmetric dimethylarginine patient group. GFR is typically calculated using the Cockroft-Gault or Modification of Diet in Renal Disease formulas, 26 based on serum creatinine levels. The diagnostic value of such GFR evaluation in cirrhotic patients with hepatorenal syndrome is controversial. [27] [28] [29] [30] 31 False high GFR values may be caused by: 1) high bilirubin levels, which make falsely underestimated creatinine levels; 2) liver failure, which deteriorates the conversion of creatine to creatinine; 3) muscle atrophy and dietary restriction in meat consumption in cirrhotic patients, leading to smaller creatinine production; and 4) high creatinine excretion via renal tubules in patients with hepatorenal syndrome.
26
As shown in this study, a significant increase in creatinine levels in recipients after transplantation may be caused by impaired renal clearance of ADMA, SDMA, and L-arginine. It should be stressed that the formulas based on creatinine levels are not ideal measurements of the GFR in these patients. [26] [27] [28] [29] [30] Our study provides interesting results on a positive correlation between SDMA and creatinine levels. SDMA, unlike ADMA, is excreted almost exclusively with urine. Therefore, SDMA may be a useful biomarker of the GFR in patients with end-stage liver failure.
32 A significant negative correlation between SDMA levels and the activity of ALT, AST, and GGT in liver recipients after transplantation is another interesting finding that requires further investigation. So far, SDMA linked pathogenically with other markers of liver injury. This hypothesis is supported by a strong negative correlation between ADMA concentrations and INR before transplantation and at day 3 after transplantation as well as a positive correlation between ADMA and bilirubin levels at day 1 after transplantation (TAbLE 3) .
We observed a significant rise in the activity of ALT and AST as well as in the levels of ADMA, SDMA, and L-arginine after liver transplantation. SDMA levels showed a negative correlation with ALT and AST activities. A significant increase in the activity of ALT and AST after transplantation may be due to reperfusion stress, administration of tacrolimus, graft ischemia during transplantation, or other causes.
3,22 An increase in ADMA and SDMA levels may be due to some compensatory mechanism, which prevents NOS from producing NO. In liver cirrhosis, a significant dilatation of arteries is common, caused by intensive NO synthesis. 22 The rise of ADMA levels after transplantation may prevent hemodynamic perturbations caused by inadequate NO production.
The study has several limitations. First, liver failure in recipients had different etiological factors. Second, the number of patients was small; therefore, it was not possible to study the effect of liver failure and its etiology on dimethylarginine levels.
Due to the risk of hepatorenal syndrome, 23-25 estimation of the glomerular filtration rate (GFR) after liver transplantation is mandatory in this has been considered to be an inactive metabolite compared with ADMA. Our results suggest that this cannot by unanimously confirmed. If dimethylarginines were the markers of hepatic damage, a positive rather than a negative correlation between SDMA and the activity of the above enzymes should be expected. As reported by Paninsic and Lebowitz, 33 almost 80% of liver recipients showed symptoms of renal failure 48 hours after transplantation. Renal failure may be even more frequent when using the novel biomarkers of kidney injury (cystatin, kidney injury molecule-1, neutrophil gelatinase-associated lipocalin, interleukin 1, and others). 33
Conclusions Patients with liver cirrhosis before transplantation have similar serum levels of ADMA, SDMA, and L-arginine as cadaver liver donors, and these parameters increase significantly after liver transplantation. The absence of significant correlations between ADMA levels and liver function indices (such as AST, ALT, GGT, natremia) may suggest that its diagnostic significance is different from that of other liver function markers in cirrhotic patients. The presence of a significant correlation between creatinine and SDMA levels both in donors and recipients suggests that the renal clearance rate of SDMA may have diagnostic value in the estimation of GFR in these patients. An increase in the levels of dimethylarginines after liver transplantation may be caused not only by graft's functional impairment but also by renal injury induced by the surgical procedure itself and/or by the use of nephrotoxic immunosuppressant drugs.
